Results First-time AOM prescriptions for adolescents We found 1,265,399 patients who met our inclusion criteria
A product that lacks evidence for its delivery method is not a credible option, however appealing the ingredient list looks
These discussions often center on everyday experiences with GLP-1 medications, including how dosing choices affect comfort, cost, and consistency
Step 2: Explain GLP-1 and Its Function Clearly explain what GLP-1 is and how it works in simple terms
On August 27, 2025, the FDA approved the first generic version of liraglutide (Saxenda) for weight loss in adults and adolescents with obesity and adults with overweight and at least one weight-related comorbid condition
Employers would save on sick days, burnout, and the downstream costs of managing chronic diseases that are directly tied to obesity